Truist Financial Cuts Incyte (NASDAQ:INCY) Price Target to $72.00
Incyte (NASDAQ:INCY – Free Report) had its price target reduced by Truist Financial from $74.00 to $72.00 in a report issued on Tuesday,Benzinga reports. They currently have a hold rating on the biopharmaceutical company’s stock. INCY has been the subject of a number of other reports. Guggenheim lowered shares of Incyte from a “buy” rating […]
Incyte (NASDAQ:INCY – Free Report) had its price target reduced by Truist Financial from $74.00 to $72.00 in a report issued on Tuesday,Benzinga reports. They currently have a hold rating on the biopharmaceutical company’s stock. INCY has been the subject of a number of other reports. Guggenheim lowered shares of Incyte from a “buy” rating […]
